Collectively, our metabolic analyses implied that FATP5 loss augments glucose flux to support the glycolytic pathway and induce ATP production, inhibiting AMPK phosphorylation and activating mTOR signaling to promote EMT and cancer cell metastasis. This evidence concerns the gene PRKAA1 and cancer.